Protecting Clients Coast to Coast

Did You Lose Money in James Hardie Industries plc (NYSE:JHX) Stock? Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against James Hardie Industries plc (“James Hardie” or the “Company”) for alleged violations of federal securities laws. The firm reminds investors that they have until December 23, 2025 to seek appointment as lead plaintiff in the class action filed against the Company. The complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that James Hardie Industries plc misled investors about the strength of its key North America Fiber Cement segment between May 20 and August 18, 2025. Despite knowing by April and early May that distributors were destocking inventory, the company falsely claimed demand remained strong and that stock levels were “normal.” Lead Plaintiff Deadline: December 23, 2025 📞 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) 💻 Or submit your information below to learn about your rights.

Did You Lose Money in Baxter International, Inc. (NYSE: BAX) Stock? Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International, Inc.  (“Baxter” or the “Company”) for alleged violations of federal securities laws. The firm reminds investors that they have until December 15, 2025 to seek appointment as lead plaintiff in the class action filed against the Company. The complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose: (a) the Novum LVP suffered systemic defects that caused widespread malfunctions, including underinfusion, overinfusion, and complete non-delivery of fluids, which exposed patients to risks of serious injury or death; (b) Baxter was notified of multiple device malfunctions, injuries, and deaths from these defects; (c) Baxter’s attempts to address these defects through customer alerts were inadequate remedial measures, when design flaws persisted and continued to cause serious harm to patients; (d) as a result, there was a heightened risk that customers would be instructed to take existing Novum LVPs out of service and that Baxter would completely pause all new sales of these pumps; and (e) based on the foregoing, Baxter’s statements about the safety, efficacy, product rollout, customer feedback and sales prospects of the Novum LVPs were materially false and misleading. If you purchased BAX securities between February 23, 2022 and July 30, 2025 , you may be eligible to recover your losses. Lead Plaintiff Deadline: December 15, 2025 📞 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) 💻 Or submit your information below to learn about your rights.

If you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD). STOCK DROP: On Monday, October 13, 2025, Tvardi Therapeutics, Inc. saw its shares plummet over 80% after disappointing preliminary data from the Phase 2 REVERT clinical trial of TTI-101 in idiopathic pulmonary fibrosis. The study was designed to assess safety, pharmacokinetics, and exploratory outcomes related to lung function. After reviewing the preliminary safety data and exploratory efficacy results, including changes in Forced Vital Capacity (FVC), the Company concluded that the study did not meet its goals. Preliminary data demonstrated patients’ baseline characteristics were similar across treatment arms, with the exception of percent predicted FVC, which was lower in the placebo-treated patients compared to the TTI-101-treated arms.

Did You Lose Money in WPP plc (NYSE: WPP) Stock? Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against WPP plc (“WPP” or the “Company”) for alleged violations of federal securities laws. The firm reminds investors that they have until December 8, 2025 to seek appointment as lead plaintiff in the class action filed against the Company. The complaint alleges that WPP and certain executives misled investors about the Company’s expected revenue for fiscal year 2025 and the strength of its media division, GroupM. While expressing confidence in new client wins and claiming to provide “cautious” guidance, WPP allegedly concealed that its media arm was losing market share and struggling to compete amid ongoing macroeconomic challenges. If you purchased WPP securities between February 27, 2025 and July 8, 2025, you may be eligible to recover your losses. Lead Plaintiff Deadline: December 8, 2025 📞 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) 💻 Or submit your information below to learn about your rights.